Bosentan - NDC Database (Page 2)

29 records found
Page:First Page2
68180-387 Apr 26, 2019
Bosentan 62.5 mg Oral Tablet by Lupin Pharmaceuticals, Inc.
68382-446 May 01, 2019
Bosentan 62.5 mg Oral Tablet, Coated by Zydus Pharmaceuticals (Usa) Inc.
68382-447 May 01, 2019
Bosentan 125 mg Oral Tablet, Coated by Zydus Pharmaceuticals (Usa) Inc.
69097-377 Jan 03, 2020
Bosentan 62.5 mg Oral Tablet, Film Coated by Cipla USA Inc.
69097-378 Jan 03, 2020
Bosentan 125 mg Oral Tablet, Film Coated by Cipla USA Inc.
70710-1508 Feb 17, 2026
Bosentan 32 mg Oral Tablet, for Suspension by Zydus Pharmaceuticals USA Inc.
70771-1017 May 01, 2019
Bosentan 62.5 mg Oral Tablet by Cadila Healthcare Limited
70771-1018 May 01, 2019
Bosentan 125 mg Oral Tablet by Cadila Healthcare Limited
70771-1908 Feb 17, 2026
Bosentan 32 mg Oral Tablet, for Suspension by Zydus Lifesciences Limited
Page:First Page2
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.